Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.15 SEK | -7.47% | +0.45% | -3.46% |
May. 15 | Iconovo AB Files Patent Application for Inhaled GLP-1 Products and Initiates Development of New Obesity Treatments | CI |
May. 06 | Sweden's Iconovo to Receive Chinese Patent for ICOres Inhaler | MT |
Sales 2024 * | 52.65M 5.05M | Sales 2025 * | 76.4M 7.33M | Capitalization | 192M 18.4M |
---|---|---|---|---|---|
Net income 2024 * | -21M -2.01M | Net income 2025 * | -25M -2.4M | EV / Sales 2024 * | 2.91 x |
Net cash position 2024 * | 38.6M 3.7M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.51 x |
P/E ratio 2024 * |
-6.03
x | P/E ratio 2025 * |
-11
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.44% |
1 day | -7.47% | ||
1 week | +0.45% | ||
Current month | -7.47% | ||
1 month | +39.38% | ||
3 months | +39.72% | ||
6 months | +30.87% | ||
Current year | -3.46% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Wäborg
CEO | Chief Executive Officer | 47 | 20-04-13 |
Orest Lastow
FOU | Founder | 60 | 12-12-31 |
Henrik Simonsen
DFI | Director of Finance/CFO | 61 | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 63 | 12-12-31 | |
Gunnar Gårdemyr
CHM | Chairman | 65 | 21-04-30 |
Ann Gidner
BRD | Director/Board Member | 58 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 11.15 | -7.47% | 116 266 |
24-05-31 | 12.05 | +13.15% | 60,436 |
24-05-30 | 10.65 | -3.18% | 70,211 |
24-05-29 | 11 | +1.85% | 82,637 |
24-05-28 | 10.8 | -2.70% | 49,951 |
Delayed Quote Nasdaq Stockholm, June 03, 2024 at 10:44 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.46% | 18.21M | |
+4.53% | 26.97B | |
-40.08% | 2.67B | |
-21.07% | 2.4B | |
+16.30% | 2.28B | |
+8.60% | 2.24B | |
-13.37% | 1.82B | |
+24.48% | 1.26B | |
-1.10% | 1.21B | |
+20.00% | 1.2B |
- Stock Market
- Equities
- ICO Stock